Insight journal - Company

Allergan: M&A activity 2005-2013

Posted on 10 September 2013

Tags: ,

Allergan has also announced 11 M&A deals since 2005, with the lead deals being the merger of Inamed Corp in 2005 and MAP Pharmaceuticals in 2013.

Abstracted from: Report: Partnering Agreements with Allergan 2005-2013

Allergan is involved in M&A activity for growth similar to its peers in the list of top pharmaceutical companies. Allergan has on occasions sought growth through strategic acquisition, for example when acquiring Esprit Pharma and MAP Pharmaceuticals.

The following figure shows the level of Allergan M&A deal announcements since 2005.

Figure 1: Allergan M&A deals 2005-2013

Allergan M and A activity per year

Source: Current Agreements, 2013

Allergan has signed 11 M&A deals since 2005. Companies acquired include:

  • MAP Pharmaceuticals
  • Esprit Pharma
  • Inamed

View the full list at Current Agreements (subscription required)

Allergan has been attracted to acquisition transactions whereby the company expands through the acquisition and assimilation of strategic target assets to realize business growth. This is evidenced by the acquisition of MAP Pharmaceuticals to access the central nervous system business.

The following figure provides a summary of the top M&A deals by headline value.

Figure 2: Top Allergan M&A deals by headline value 2005-2013

Allergan M and A top deals

Source: Current Agreements, 2013

Our report provides more detailed insight into the details of each deal. See: Report: Partnering Agreements with Allergan 2005-2013

Allergan M&A at Current Agreements 

View all M&A deals for Allergan: 2013 | 2012 | 2011 | 2010 | 2009 | 20082007 | 2006 | 2005

Full details on each deal can be found at CurrentAgreements (subscription required)

Or purchase report: Report: Partnering Agreements with Allergan 2005-2013

 

More

Summary profile data for Allergan

Partnering interests for Allergan

Partnering activity for Allergan

 

Available reports from Current Partnering

Report: Partnering Agreements with Allergan 2005-2013

Report: Top 50 Big Pharma Partnering and M&A Deal Trends

 

Available resources for deal coverage for Allergan

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Allergan company profile, recent partnering, M&A and financing news and articles

 

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply